Anaveon
A start up based in Switzerland that develops biologics to modulate the functions of cytokines and provide substantial therapeutic benefits to cancer patients. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€367—550m (Dealroom.co estimates Dec 2021.)
Company register number CH-280.3.021.839-0
Basel Basel-City (HQ)
Authorizing premium user...